Myocardial Gene Expression of T-bet, GATA-3, Ror-gamma t, FoxP3, and Hallmark Cytokines in Chronic Chagas Disease Cardiomyopathy: An Essentially Unopposed T(H)1-Type Response

Carregando...
Imagem de Miniatura
Citações na Scopus
52
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
HINDAWI PUBLISHING CORPORATION
Citação
MEDIATORS OF INFLAMMATION, article ID 914326, 9p, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background. Chronic Chagas disease cardiomyopathy (CCC), a late consequence of Trypanosoma cruzi infection, is an inflammatory cardiomyopathy with prognosis worse than those of noninflammatory etiology (NIC). Although the T cell-rich myocarditis is known to play a pathogenetic role, the relative contribution of each of the functional T cell subsets has never been thoroughly investigated. We therefore assessed gene expression of cytokines and transcription factors involved in differentiation and effector function of each functional T cell subset (T(H)1/T(H)2/T(H)17/Treg) in CCC, NIC, and heart donor myocardial samples. Methods and Results. Quantitative PCR showed markedly upregulated expression of IFN-gamma and transcription factor T-bet, and minor increases of GATA-3; FoxP3 and CTLA-4; IL-17 and IL-18 in CCC as compared with NIC samples. Conversely, cytokines expressed by T(H)2 cells (IL-4, IL-5, and IL-13) or associated with Treg (TGF-beta and IL-10) were not upregulated in CCC myocardium. Expression of T(H)1-related genes such as T-bet, IFN-gamma, and IL-18 correlated with ventricular dilation, FoxP3, and CTLA-4. Conclusions. Results are consistent with a strong local T(H)1-mediated response in most samples, possibly associated with pathological myocardial remodeling, and a proportionally smaller FoxP3(+)CTLA4(+) Treg cell population, which is unable to completely curb IFN-gamma production in CCC myocardium, therefore fueling inflammation.
Palavras-chave
Referências
  1. Abel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523
  2. Araujo FF, 2007, FRONT BIOSCI, V12, P2797, DOI 10.2741/2273
  3. Araujo-Jorge TC, 2002, J INFECT DIS, V186, P1823, DOI 10.1086/345882
  4. Arguello RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035966
  5. Bafica A, 2006, J IMMUNOL, V177, P3515
  6. Bestetti RB, 1997, INT J CARDIOL, V60, P187, DOI 10.1016/S0167-5273(97)00083-1
  7. Bilate AMB, 2008, REV INST MED TROP SP, V50, P67, DOI 10.1590/S0036-46652008000200001
  8. Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
  9. Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200
  10. Coura JR, 2007, MEM I OSWALDO CRUZ, V102, P113, DOI 10.1590/S0074-02762007000900018
  11. Cunha-Neto E, 2001, AUTOIMMUNITY, V34, P187, DOI 10.3109/08916930109007383
  12. Cunha-Neto E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000900032
  13. Cunha-Neto E, 2005, AM J PATHOL, V167, P305, DOI 10.1016/S0002-9440(10)62976-8
  14. de Araujo FF, 2012, IMMUNOBIOLOGY, V217, P768, DOI 10.1016/j.imbio.2012.04.008
  15. de Araujo FF, 2011, HUM PATHOL, V42, P299, DOI 10.1016/j.humpath.2010.10.002
  16. Dinarello CA, 2003, J INFECT DIS, V187, pS370, DOI 10.1086/374751
  17. Dong L, 2006, CHINESE MED J-PEKING, V119, P1396
  18. dos Reis M. A., 2012, CLIN DEV IMMUNOL, V2012
  19. Fonseca SG, 2007, SCAND J IMMUNOL, V66, P362, DOI 10.1111/j.1365-3083.2007.01987.x
  20. Frade A. F., 2013, PLOS ONE
  21. Gomes JAS, 2005, INFECT IMMUN, V73, P7960, DOI 10.1128/IAI.73.12.7960-7966.2005
  22. Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003
  23. Guedes PMM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001630
  24. HIGUCHI MD, 1987, CLIN CARDIOL, V10, P665
  25. HIGUCHI MD, 1993, VIRCHOWS ARCH A, V423, P157, DOI 10.1007/BF01614765
  26. Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003
  27. Jiang HK, 2010, CIRC J, V74, P2410, DOI 10.1253/circj.CJ-10-0234
  28. Jorge MT, 2003, ANN TROP MED PARASIT, V97, P139, DOI 10.1179/000349803235001561
  29. Kirchhoff LV, 2004, FRONT BIOSCI, V9, P706, DOI 10.2741/1255
  30. Kmieciak M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-89
  31. Magalhaes LMD, 2013, J INFECT DIS, V207, P661, DOI 10.1093/infdis/jis724
  32. Marino APMP, 2004, CIRCULATION, V110, P1443, DOI 10.1161/01.CIR.0000141561.15939.EC
  33. Michailowsky V, 2001, AM J PATHOL, V159, P1723, DOI 10.1016/S0002-9440(10)63019-2
  34. Miller SA, 2009, IMMUNOLOGY, V126, P306, DOI 10.1111/j.1365-2567.2008.03040.x
  35. Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423
  36. Nogueira LG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001867
  37. Reddy VS, 2008, J CELL PHYSIOL, V215, P697, DOI 10.1002/jcp.21348
  38. REIS DD, 1993, AM J TROP MED HYG, V48, P637
  39. REIS DD, 1993, AM J TROP MED HYG, V49, P192
  40. Reis MM, 1997, CLIN IMMUNOL IMMUNOP, V83, P165, DOI 10.1006/clin.1997.4335
  41. Ribeirao M, 2000, PARASITE IMMUNOL, V22, P49, DOI 10.1046/j.1365-3024.2000.00260.x
  42. Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095
  43. Saraiva RM, 2013, T ROY SOC TROP MED H, V107, P518, DOI 10.1093/trstmh/trt050
  44. Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011
  45. Talvani A, 2004, J INFECT DIS, V189, P214, DOI 10.1086/380803
  46. Teixeira LK, 2005, MEM I OSWALDO CRUZ, V100, P137, DOI 10.1590/S0074-02762005000900024
  47. Teixeira MM, 2002, TRENDS PARASITOL, V18, P262, DOI 10.1016/S1471-4922(02)02283-3
  48. Tone M, 1997, J IMMUNOL, V159, P6156
  49. Torzewski M, 2012, AM J PATHOL, V180, P73, DOI 10.1016/j.ajpath.2011.09.006